The Food and Drug Administration is proposing a system for approving customized drugs and medical treatments for patients with rare or hard-to-treat diseases. The pathway laid out Monday is aimed ...

According to an FDA press release, the draft guidance "focuses on therapies that target a specific genetic, cellular, or molecular abnormality and are designed to correct or modify the underlying ...

The UK National Screening Committee issued draft guidance in November saying the routine checks should only be offered in ...

Many law enforcement agencies are relying on crowdfunding to pay for genetic genealogy, which has helped solve hundreds of ...

Researchers are evaluating the P-CARE model, which integrates results from a blended genome-exome sequencing assay and family ...

Dr Sandeep Nayak details how genetic counselling and BRCA testing identify breast cancer risks, offering proactive screening and advanced surgery in Bangalore.

A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

A study of ancient human DNA from a wetland region in Belgium, western Germany, and the Netherlands yielded surprising ...

Within a few centuries, the genetic landscape of the Rhine-Meuse region, including the wetlands, was completely reshaped. Our ...

Today, the first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in women’s health. Clairity Breast, a product of Clairity Inc., is the first FDA-authorized ...